explore -WSS

explore

author：leisure time 2025-09-27 10:00:23 - browse：5459

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Medicare drug price negotiation continues, as pharma counteroffers

explore

WSS

Readout Newsletter: BridgeBio, Akero, and human embryo models

For AI in health care standards, federal regulators join with industry group

Doctor of U.S. President Joe Biden says he is fit for duty

CDC advisory group OKs chikungunya vaccine

Streamlined flu vaccines recommended by FDA advisory panel

A new approach to psychiatric drug development

hotspot

explore

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Harvard's David Sinclair gets blowback over aging

Affirmative action in medical school literally saved lives

Medicare isn't yet testing food as medicine

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Color Health wants to make cancer screenings convenient

Walensky prepares to leave CDC — and Congress — behind

First over

Duchenne breakthrough therapy leaves behind pioneering families

Children’s Hospital revives plan for pedestrian bridge

leisure time

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Microsoft's Peter Lee: Generative AI could help doctors be more human

5 ways to address the shortage of health care workers

Children’s Hospital revives plan for pedestrian bridge

Virtual repurposing can help discover new uses for existing drugs

hotspot

Wikipedia

explore

hotspot